CAS 51997-43-4

Carazolol hydrochloride

Description:

Carazolol hydrochloride is a pharmaceutical compound primarily recognized for its role as a non-selective beta-adrenergic antagonist. It is often utilized in research settings to study the effects of beta-blockade on various physiological processes. The substance typically appears as a white to off-white crystalline powder and is soluble in water, which facilitates its use in various formulations. Carazolol hydrochloride exhibits a range of pharmacological effects, including the reduction of heart rate and blood pressure, making it relevant in cardiovascular studies. Its mechanism of action involves blocking beta-adrenergic receptors, which are critical in mediating the effects of catecholamines like adrenaline. Additionally, the compound may have implications in the treatment of conditions such as hypertension and anxiety disorders. As with many pharmacological agents, the safety profile and potential side effects are important considerations, necessitating careful evaluation in clinical contexts. Overall, Carazolol hydrochloride serves as a valuable tool in both therapeutic applications and scientific research.

Formula: C₁₈H₂₂N₂O₂·HCl

Synonyms:

• Carazolol HCL
• Conducton hydrochloride
• Nsc305336
• 1-(9H-carbazol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol hydrochloride

Carazolol-d6

CAS: 51997-43-4, 57775-29-8

Formula: C₁₈H₁₆D₆N₂O₂

Molecular weight: 304.42

Ref: 4Z-C-357002

Carazolol Hydrochloride Salt

Controlled Product

CAS: 51997-43-4

Applications Carazolol is a promising high-affinity beta-adrenergic receptor ligand for the noninvasive determination of beta receptor status using PET.
References Berridge, M.S., et al.: J. Nucl. Med., 35(10), 1665 (1994)

Formula: C₁₈H₂₂N₂O₂·ClH

Color and Shape: Neat

Molecular weight: 334.84

Ref: TR-C175810